Abstract
Background: The first case of the novel coronavirus disease 2019 (COVID-19) in Libya was diagnosed in March 2020. We aimed to determine the epidemiological, clinical, and laboratory characteristics of COVID-19 in Libya.
Method: In this retrospective descriptive study, we analyzed the demographics, initial clinical presentation, history, comorbidities, laboratory findings, complications, and outcomes of hospitalized patients with COVID-19 at several centers in the Western part of Libya between March 24, 2020, and December 3, 2020.
Results: The study included 811 (67.2%) men and 396 (32.8%) women. The median (interquartile range [IQR]) age was 56 (40-64). A total of 173 (14.3%) patients developed respiratory distress syndrome, while 70 (5.8%) developed circulatory shock and hypotension; 190 (15.7%) were admitted to the intensive care unit. Acute cardiac injury occurred in 27 (2.2%) patients, and 45 (3.7%) developed arrhythmia. Acute kidney injury occurred in 44 (3.6%) patients. Of the patients admitted during the study period, 149 (12.3%) died. The predominant comorbidities ordered in a descending manner were as follows; diabetes mellitus, presented 490 (40.6%), hypertension in 414 (34.3%), chronic kidney disease in 114 (9.4%), and lung diseases in 103 (8.5%). The total white blood cell, neutrophil; monocyte; D-dimer; creatinine kinase; creatine kinase-MB; creatinine; total bilirubin; alanine and aspartate aminotransferase; and hypersensitive troponin were increased among non-survivors, whereas lymphocyte and platelet counts were decreased among non-survivors.
Conclusion: This is the first report of the clinical presentations and laboratory findings in patients hospitalized with COVID-19 in Libya. Libyan authorities must implement several restrictions to control the pandemic. However, incoming international travelers pose a challenge to the local authorities, especially with the recent discovery of new variants.
Keywords: Africa; Comorbidity; Coronavirus; Epidemiology; Respiratory distress syndrome; Severe acute respiratory syndrome.
【저자키워드】 Respiratory distress syndrome, coronavirus, Epidemiology, Comorbidity, Africa, Severe acute respiratory syndrome, 【초록키워드】 COVID-19, coronavirus disease, Respiratory distress syndrome, Coronavirus disease 2019, pandemic, intensive care, creatine, neutrophil, Comorbidities, Diabetes Mellitus, intensive care unit, Lung disease, Comorbidity, D-dimer, Local, Acute kidney injury, Chronic kidney disease, diabetes, outcome, hospitalized patients, novel coronavirus disease, hypertension, variants, Novel coronavirus, arrhythmia, Laboratory, Acute cardiac injury, monocyte, Kidney injury, cardiac injury, Severe acute respiratory syndrome, lymphocyte, Shock, White blood cell, International, Hypotension, Lung diseases, Patient, Kidney disease, Aspartate aminotransferase, Platelet, complications, laboratory characteristics, age, epidemiological, creatine kinase, women, patients, Creatine kinase-MB, retrospective, creatinine, Injury, clinical presentation, distress, Libya, Bilirubin, demographics, blood cell, respiratory distress, platelet counts, circulatory shock, interquartile range, Non-survivors, acute respiratory syndrome, creatinine kinase, total bilirubin, Clinical presentations, study period, syndrome, aspartate, Alanine, men, initial, analyzed, occurred, died, the patient, diagnosed, median, determine, hospitalized patient, predominant, descending, hypersensitive, patients hospitalized, with COVID-19, 【제목키워드】 hospitalized COVID-19 patient, clinical presentation, initial,